Barbara A. Miller

Barbara A. Miller

Auto-generated profile, based on publicly available information

Barbara A. Miller

Departments of Pediatrics, and Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Cell Calcium
Verified
Journal Article
Closed access
BMBarbara A. Miller
Barbara A. Miller

26 July 2011 in Stem Cells
Verified
Journal Article
Open access
PDF file
BSBin Shen
Bin Shen
ZXZheng Xiang
Zheng Xiang
BMBarbara Miller
Barbara Miller
GLGordon Louie
Gordon Louie
WWWen yuan Wang
Wen yuan Wang
LWLei Wang
Lei Wang
Although unnatural amino acids (Uaas) have been genetically encoded in bacterial, fungal, and mammalian cells using orthogonal transfer RNA (tRNA)/aminoacyl-tRNA synthetase pairs, applications of this method to a wider range of specialized cell types, such as stem cells, still face challenges. While relatively straightforward in stem cells, transient expression lacks sufficient temporal resolution to afford reasonable levels of Uaa incorporation and to allow for the study of the longer term differentiation process of stem cells. Moreover, Uaa incorporation may perturb differentiation. Here, we describe a lentiviral-based gene delivery method to stably incorporate Uaas into proteins expressed in neural stem cells, specifically HCN-A94 cells. The transduced cells differentiated into neural progenies in the same manner as the wild-type cells. By genetically incorporating a fluorescent Uaa into a voltage-dependent membrane lipid phosphatase, we show that this Uaa optically reports the conformational change of the voltage-sensitive domain in response to membrane depolarization. The method described here should be generally applicable to other stem cells and membrane proteins.

20 April 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
SCShu-Jen Chen
Shu-Jen Chen
LBLei Bao
Lei Bao
KKKerry Keefer
Kerry Keefer
SSSanthanam Shanmughapriya
Santhanam Shanmughapriya
LCLonggui Chen
Longgui Chen
BMBarbara A. Miller
Barbara A. Miller
Transient receptor potential melastatin 2 (TRPM2) ion channel has an essential function in maintaining cell survival following oxidant injury. Here, we show that TRPM2 is highly expressed in acute myeloid leukemia (AML). The role of TRPM2 in AML was studied following depletion with CRISPR/Cas9 technology in U937 cells. In in vitro experiments and in xenografts, depletion of TRPM2 in AML inhibited leukemia proliferation, and doxorubicin sensitivity was increased. Mitochondrial function including oxygen consumption rate and ATP production was reduced, impairing cellular bioenergetics. Mitochondrial membrane potential and mitochondrial calcium uptake were significantly decreased in depleted cells. Mitochondrial reactive oxygen species (ROS) were significantly increased, and Nrf2 was decreased, reducing the antioxidant response. In TRPM2-depleted cells, ULK1, Atg7, and Atg5 protein levels were decreased, leading to autophagy inhibition. Consistently, ATF4 and CREB, two master transcription factors for autophagosome biogenesis, were reduced in TRPM2-depleted cells. In addition, Atg13 and FIP200, which are known to stabilize ULK1 protein, were decreased. Reconstitution with TRPM2 fully restored proliferation, viability, and autophagy; ATF4 and CREB fully restored proliferation and viability but only partially restored autophagy. TRPM2 expression reduced the elevated ROS found in depleted cells. These data show that TRPM2 has an important role in AML proliferation and survival through regulation of key transcription factors and target genes involved in mitochondrial function, bioenergetics, the antioxidant response, and autophagy. Targeting TRPM2 may represent a novel therapeutic approach to inhibit myeloid leukemia growth and enhance susceptibility to chemotherapeutic agents through multiple pathways.

1 October 2018 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
PDF file
IHIwona Hirschler-Laszkiewicz
Iwona Hirschler-Laszkiewicz
SCShu-Jen Chen
Shu-Jen Chen
LBLei Bao
Lei Bao
JWJuFang Wang
JuFang Wang
XZXue-Qian Zhang
Xue-Qian Zhang
BMBarbara A. Miller
Barbara A. Miller
Transient receptor potential melastatin channel subfamily member 2 (TRPM2) has an essential function in cell survival and is highly expressed in many cancers. Inhibition of TRPM2 in neuroblastoma by depletion with CRISPR technology or expression of dominant negative TRPM2-S has been shown to significantly reduce cell viability. Here, the role of proline-rich tyrosine kinase 2 (Pyk2) in TRPM2 modulation of neuroblastoma viability was explored. In TRPM2-depleted cells, phosphorylation and expression of Pyk2 and cAMP-responsive element-binding protein (CREB), a downstream target, were significantly reduced after application of the chemotherapeutic agent doxorubicin. Overexpression of wild-type Pyk2 rescued cell viability. Reduction of Pyk2 expression with shRNA decreased cell viability and CREB phosphorylation and expression, demonstrating Pyk2 modulates CREB activation. TRPM2 depletion impaired phosphorylation of Src, an activator of Pyk2, and this may be a mechanism to reduce Pyk2 phosphorylation. TRPM2 inhibition was previously demonstrated to decrease mitochondrial function. Here, CREB, Pyk2, and phosphorylated Src were reduced in mitochondria of TRPM2-depleted cells, consistent with their role in modulating expression and activation of mitochondrial proteins. Phosphorylated Src and phosphorylated and total CREB were reduced in TRPM2-depleted nuclei. Expression and function of mitochondrial calcium uniporter (MCU), a target of phosphorylated Pyk2 and CREB, were significantly reduced. Wild-type TRPM2 but not Ca2+-impermeable mutant E960D reconstituted phosphorylation and expression of Pyk2 and CREB in TRPM2-depleted cells exposed to doxorubicin. Results demonstrate that TRPM2 expression protects the viability of neuroblastoma through Src, Pyk2, CREB, and MCU activation, which play key roles in maintaining mitochondrial function and cellular bioenergetics.

28 March 2022 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
PZPengyu Zong
Pengyu Zong
JFJianlin Feng
Jianlin Feng
ZYZhichao Yue
Zhichao Yue
AYAlbert S. Yu
Albert S. Yu
JVJean Vacher
Jean Vacher
LYLixia Yue
Lixia Yue

1 August 1996 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
EGE. Gorczynska
E. Gorczynska
PHP. L. Huddie
P. L. Huddie
BMB. A. Miller
B. A. Miller
IMIan Mellor
Ian Mellor
HVH. Vais
H. Vais
PUP. N. R. Usherwood
P. N. R. Usherwood